Non-Valvular Atrial Fibrillation
Showing 26 - 50 of >10,000
The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial
Recruiting
- The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation
- Watchman FLX Device
-
Aarhus, DenmarkAarhus University Hospital
Jan 26, 2023
Atrial Fibrillation Trial in Padova
Completed
- Atrial Fibrillation
-
Padova, ItalyPadua University Hospital
Aug 6, 2022
Oral Anticoagulants in Italian Elderly Non-Valvular Atrial
Recruiting
- Non-Valvular Atrial Fibrillation (NVAF)
-
Milano, MI, ItalyEcol Studio SpA
Jan 31, 2022
Baseline Concentration of Direct Oral Anticoagulant and
Recruiting
- Atrial Fibrillation
- Anticoagulant-induced Bleeding
-
Cremona, ItalySophie Testa
Jul 19, 2022
Stroke and Non-Central Nervous Systemic Embolism in Renally
Completed
- Non-valvular Atrial Fibrillation (NVAF)
- Rivaroxaban(Xarelto,BAY 59-7939)
-
Multiple Locations, Korea, Republic ofMany locations
Dec 21, 2021
Evaluate the Safety and Efficacy of Apixaban Trial in Shanghai (Oral apixaban)
Recruiting
- Evaluate the Safety and Efficacy of Apixaban
- Oral apixaban
-
Shanghai, ChinaZhongshan Hospital
Oct 16, 2022
Non-Valvular Atrial Fibrillation Trial in Worldwide (Omega™LAA Occluder implantation)
Recruiting
- Non-Valvular Atrial Fibrillation
- Omega™LAA Occluder implantation
-
København, Blegdamsvej 9, Denmark
- +7 more
Mar 10, 2022
Atrial Fibrillation Trial in Tbilisi (Left Atrial Appendage Closure)
Active, not recruiting
- Atrial Fibrillation
- Left Atrial Appendage Closure
-
Tbilisi, Georgia
- +1 more
Aug 15, 2022
Stroke in Patients With Non-valvular Atrial Fibrillation
Active, not recruiting
- Atrial Fibrillation
- left atrial appendage occluder implantation
-
Moscow, Russian Federation. National Research Center for Preventive Medicine of the Minist
Dec 24, 2021
Atrial Fibrillation Trial (Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor, Rhythm control and anticoagulation)
Not yet recruiting
- Atrial Fibrillation
- Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
- Rhythm control and anticoagulation
- (no location specified)
Aug 14, 2023
Learn More About Benefits and Side-effects of Drugs Rivaroxaban
Completed
- Atrial Fibrillation
- Rivaroxaban (Xarelto, BAY59-7939)
- +2 more
-
Many Sites, United KingdomMany facilities
Oct 27, 2021
Atrial Fibrillation, Medication Adherence Trial in Fort Wayne (Health Messaging (Non-Procedural))
Completed
- Atrial Fibrillation
- Medication Adherence
- Health Messaging (Non-Procedural)
-
Fort Wayne, IndianaParkview Research Center; Parkview Health
Oct 26, 2021
Elderly Belgian NVAF That Are Treated WithNOAC for This
Completed
- Non-Valvular Atrial Fibrillation
- Non-VKA Oral Anticoagulants (NOAC)
-
Multiple Locations, BelgiumMany Locations
Mar 21, 2022
Atrial Fibrillation, Anticoagulants and Bleeding Disorders Trial in Netherlands (Left atrial appendage occlusion (Watchman FLX
Recruiting
- Atrial Fibrillation
- Anticoagulants and Bleeding Disorders
- Left atrial appendage occlusion (Watchman FLX or Amplatzer Amulet)
-
Leeuwarden, Friesland, Netherlands
- +13 more
Dec 19, 2022
Thromboembolism in Cancer Patients: Experience atComprehensive
Completed
- Cancer
- +3 more
- Retrospective Chart Review
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 22, 2022
Dementia, Cognition Disorders, Cerebral Ischemic Events Trial in Murray (Dabigatran Etexilate, Warfarin)
Completed
- Dementia
- +2 more
- Dabigatran Etexilate
- Warfarin
-
Murray, UtahIntermountain Heart Institute
Aug 30, 2021
Real Life of New Oral Anticoagulants and Vitamin K Antagonists
Completed
- Atrial Fibrillation
- Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban
- Vitamin K antagonist: warfarin, fluindione, acenocoumarol
-
Paris, FranceAssistance Publique Hôpitaux de Paris
Mar 28, 2022
Non-valvular Atrial Fibrillation Trial in Kansas City (Alive Cor Kardia mobile electrocardiogram monitor)
Recruiting
- Non-valvular Atrial Fibrillation
- Alive Cor Kardia mobile electrocardiogram monitor
-
Kansas City, MissouriSaint Luke's Health System
Jan 3, 2022
Rivaroxaban in Patients With Atrial Fibrillation Undergoing PCI
Completed
- Non-valvular Atrial Fibrillation
- +3 more
-
Bad Nauheim, Germany
- +12 more
Mar 30, 2022
Non-valvular Atrial Fibrillation Trial in Montpellier (Xarelto, Experimental: Personalized information intervention)
Completed
- Non-valvular Atrial Fibrillation
- Xarelto
- Experimental: Personalized information intervention
-
Montpellier, FranceHeart and vascular diseases service
Jul 19, 2021
Valvular Heart Disease Trial in São Paulo (Rivaroxaban, Warfarin)
Completed
- Valvular Heart Disease
-
São Paulo, SP, BrazilAssociação do Sanatório Sírio - Hospital do Coração HCor
Apr 4, 2022
Cerebral Stroke, Thrombosis, Deep Vein, Pulmonary Embolism Trial
Withdrawn
- Cerebral Stroke
- +2 more
- (no location specified)
Nov 14, 2021
Atrial Fibrillation Trial in Durham (Patient Decision Support Tool)
Not yet recruiting
- Atrial Fibrillation
- Patient Decision Support Tool
-
Durham, North CarolinaDuke University Medical Center
Jul 7, 2021
Atrial Fibrillation, Left Atrial Appendage Thrombosis, CVA Trial in Detroit (LAmbreTM Left Atrial Appendage Closure System)
Not yet recruiting
- Atrial Fibrillation
- +2 more
- LAmbreTM Left Atrial Appendage Closure System
-
Detroit, MichiganHenry Ford Hospital
Feb 15, 2022